Parameter
| Biomarker | Ψ | Full name | Pseudouridine | Molecular Type | Nucleic acid |
|---|---|---|---|---|---|
| Molecular Formula | C9H12N2O6 | Molecular Weight | 244.20 g/mol | Core Functional Dimensions | Diagnosis, prognosis |
| Disease | PCa | Disease Subtypes | / | ||
| Organ | Prostate | Test Sample / Technology Platform | blood, urine, tumor tissue (ELISA, IHC, flow cytometry, H-NMR) | ||
| Pathobiological Mechanisms | The rapid proliferation and metabolism of cancer cells lead to increased RNA metabolism and elevated pseudouridine concentration. | ||||
| Clinical Availability Status | Research verification | ||||
| Notes and Dynamics | Large-scale clinical validation is currently underway. | ||||